Spots Global Cancer Trial Database for Treatment Frequency and Satisfaction in Patients With Advanced Prostate Cancer
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Treatment Frequency and Satisfaction in Patients With Advanced Prostate Cancer
Official Title: Treatment Frequency and Satisfaction in Patients With Advanced Prostate Cancer
Study ID: NCT01441713
Conditions
Interventions
Study Description
Brief Summary: Patients with advanced prostate cancer usually receive some kind of pharmaceutical castration or undergo surgical castration. At the investigators department the pharmaceutical treatment is most often given with a 3 month interval. Over the last few years new drugs, which allow for lees frequent treatment, have been developed. The purpose of this study is to assess how the treatment affects patients and if our current patients would prefer to receive treatment at different intervals than they do at the present time. At the same time the investigators will assess how surgical treatment affects our patients. This will be assessed by patient questionnaires administered at our clinic.
Detailed Description:
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: MALE
Healthy Volunteers: No
Locations
Department of urology, Herlev Hospital, Herlev, , Denmark
Contact Details
Name: Mikkel Fode, MD
Affiliation: Herlev Hospital, University of Copenhagen
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
